These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
174 related articles for article (PubMed ID: 9921699)
21. Clinical efficacy of mirtazapine: a review of meta-analyses of pooled data. Kasper S Int Clin Psychopharmacol; 1995 Dec; 10 Suppl 4():25-35. PubMed ID: 8930007 [TBL] [Abstract][Full Text] [Related]
22. Lithium but not carbamazepine augments antidepressant efficacy of mirtazapine in unipolar depression: an open-label study. Schüle C; Baghai TC; Eser D; Nothdurfter C; Rupprecht R World J Biol Psychiatry; 2009; 10(4 Pt 2):390-9. PubMed ID: 18609420 [TBL] [Abstract][Full Text] [Related]
23. Double-blind, randomized comparison of mirtazapine and paroxetine in elderly depressed patients. Schatzberg AF; Kremer C; Rodrigues HE; Murphy GM; Am J Geriatr Psychiatry; 2002; 10(5):541-50. PubMed ID: 12213688 [TBL] [Abstract][Full Text] [Related]
24. Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Nemeroff CB; Evans DL; Gyulai L; Sachs GS; Bowden CL; Gergel IP; Oakes R; Pitts CD Am J Psychiatry; 2001 Jun; 158(6):906-12. PubMed ID: 11384898 [TBL] [Abstract][Full Text] [Related]
25. Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: superiority over imipramine. Cankurtaran ES; Ozalp E; Soygur H; Akbiyik DI; Turhan L; Alkis N Support Care Cancer; 2008 Nov; 16(11):1291-8. PubMed ID: 18299900 [TBL] [Abstract][Full Text] [Related]
26. A double-blind randomized study comparing imipramine with fluvoxamine in depressed inpatients. van den Broek WW; Birkenhäger TK; Mulder PG; Bruijn JA; Moleman P Psychopharmacology (Berl); 2004 Oct; 175(4):481-6. PubMed ID: 15243735 [TBL] [Abstract][Full Text] [Related]
27. Mirtazapine augmentation in the treatment of refractory depression. Carpenter LL; Jocic Z; Hall JM; Rasmussen SA; Price LH J Clin Psychiatry; 1999 Jan; 60(1):45-9. PubMed ID: 10074878 [TBL] [Abstract][Full Text] [Related]
28. Double-blind study of mirtazapine and placebo in hospitalized patients with major depression. Vartiainen H; Leinonen E Eur Neuropsychopharmacol; 1994 Jun; 4(2):145-50. PubMed ID: 7919944 [TBL] [Abstract][Full Text] [Related]
29. A meta-analysis of eight randomized, double-blind, controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety. Fawcett J; Barkin RL J Clin Psychiatry; 1998 Mar; 59(3):123-7. PubMed ID: 9541155 [TBL] [Abstract][Full Text] [Related]
30. Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression. Szegedi A; Müller MJ; Anghelescu I; Klawe C; Kohnen R; Benkert O J Clin Psychiatry; 2003 Apr; 64(4):413-20. PubMed ID: 12716243 [TBL] [Abstract][Full Text] [Related]
31. Mirtazapine vs. amitriptyline vs. placebo in the treatment of major depressive disorder. Smith WT; Glaudin V; Panagides J; Gilvary E Psychopharmacol Bull; 1990; 26(2):191-6. PubMed ID: 2236455 [TBL] [Abstract][Full Text] [Related]
32. Trait anxiety and the effect of a single high dose of diazepam in unipolar depression. Bruijn JA; Moleman P; van den Broek WW; Mulder PG J Psychiatr Res; 2001; 35(6):331-7. PubMed ID: 11684140 [TBL] [Abstract][Full Text] [Related]
33. Mirtazapine monotherapy versus combination therapy with mirtazapine and aripiprazole in depressed patients without psychotic features: a 4-week open-label parallel-group study. Schüle C; Baghai TC; Eser D; Hecht S; Hermisson I; Born C; Häfner S; Nothdurfter C; Rupprecht R World J Biol Psychiatry; 2007; 8(2):112-22. PubMed ID: 17455104 [TBL] [Abstract][Full Text] [Related]
34. A double-blind study comparing the efficacy and tolerability of mirtazapine and doxepin in patients with major depression. Marttila M; Jääskeläinen J; Järvi R; Romanov M; Miettinen E; Sorri P; Ahlfors U; Zivkov M Eur Neuropsychopharmacol; 1995 Dec; 5(4):441-6. PubMed ID: 8998395 [TBL] [Abstract][Full Text] [Related]
35. A risk-benefit assessment of mirtazapine in the treatment of depression. Kasper S; Praschak-Rieder N; Tauscher J; Wolf R Drug Saf; 1997 Oct; 17(4):251-64. PubMed ID: 9352961 [TBL] [Abstract][Full Text] [Related]
36. Prevention and treatment of poststroke depression with mirtazapine in patients with acute stroke. Niedermaier N; Bohrer E; Schulte K; Schlattmann P; Heuser I J Clin Psychiatry; 2004 Dec; 65(12):1619-23. PubMed ID: 15641866 [TBL] [Abstract][Full Text] [Related]